Overview
- Health groups and hospitals ran coordinated awareness drives on June 10–11 to urge men over 50 and higher‑risk men to get PSA tests and preventive urology checks.
- Clinical reports from ASCO 2026 highlighted a strategy of intensified perioperative hormonal therapy that cut the risk of metastasis in high‑risk localized prostate cancer.
- Hospitals and clinics are broadening use of multiparametric MRI before biopsy, PET‑PSMA imaging, image‑fusion biopsies and robotic surgery to reduce unnecessary biopsies and target aggressive tumors.
- Argentina has approved radioligand therapy for clinical use and centers across the region report growing access, while Peru still records a high share of late‑stage diagnoses linked to fear and misinformation about exams.
- Wider screening and guideline‑driven pathways matter because early detection by PSA plus MRI yields cure rates near 90–95% for localized disease, so public education to counter myths is key to lowering deaths and preserving quality of life.